Breakthrough Consortium (MRFBC) Pilot Awards Grant

The Melanoma Research Foundation (MRF) invites applications for the Breakthrough Consortium (MRFBC) Pilot Awards, offering $50,000 for innovative clinical/translational research. This one-year pilot program encourages both tenured and non-tenured faculty to submit proposals that could lead to larger multicenter grants. Preliminary data is not required, but successful applications must demonstrate novel approaches in the fight against melanoma, contributing to the MRF's mission of advancing effective treatments and raising awareness.

Meet the MRF
Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also educates patients and physicians about prevention, diagnosis and the treatment of melanoma. The MRF is an active advocate for the melanoma community, helping to raise awareness of this disease and the need for a cure. The MRF’s website is the premier source for melanoma information seekers.This one-year pilot proposal for $50,000 focuses on clinical/ translational research. As this is a pilot award, preliminary data is not required. The goal of the pilot proposal is to create findings that could then lend themselves to larger, multicenter grant proposals. Both tenured and non-tenured track faculty are encouraged to apply. Successful applications will emphasize novel, innovative translational proposals focused on clinical/translational research. Research must detail how findings may lend themselves to larger, multicenter grant proposals.
Pilot Awards: The goal of this award is to create findings that could then lend themselves to larger, multicenter grant proposals. Both tenured and non-tenured track faculty are encouraged to apply.